PizzaTrader Stock of the Month: March 2026

Abbott IP chief: ‘Firms without AI policies scare me’ - Life Sciences Intellectual Property Review

Abbott Laboratories $ABT Shares Sold by Victory Capital Management Inc. - MarketBeat

Abbott Laboratories $ABT Shares Sold by Orion Porfolio Solutions LLC - MarketBeat

Abbott Faces Trial Over Claims Its Infant Formula Caused Bowel Disease in Premature Babies - The Indian Practitioner

Trial over Abbott Laboratories’ formula for premature babies set to begin this week - Times West Virginian

Crossmark Global Holdings Inc. Purchases 12,373 Shares of Abbott Laboratories $ABT - MarketBeat

Respiratory Disease Testing Market Global Forecast Report 2026-2032: $9.32 Bn Opportunities in Integrating Advanced Diagnostics, Leveraging Partnerships, and Enhancing Supply Resilience

(ABT) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Help me cut the cord in Chicago

Abbott Labs to face trial on infant formula - The Economic Times

Intraday drop: ABT.SW stock down 12.00% on SIX as price hits CHF88.00, what analysts watch next - Meyka

Trial over Abbott Laboratories’ formula for premature babies set to begin in Chicago this week - The Daily Gazette

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Daywatch: Trial over Abbott Laboratories’ formula for premature babies set to begin - Chicago Tribune

Abbott set to face trial over claims premature infant formula caused deadly disease - Reuters

Trial over Abbott Laboratories’ formula for premature babies set to begin in Cook County this week - Chicago Tribune

Dimensional Fund Advisors LP Purchases 169,115 Shares of Abbott Laboratories $ABT - MarketBeat

Abbott Laboratories EVP Cushman sells $30k in stock By Investing.com - Investing.com Australia

Abbott Laboratories EVP Cushman sells $30k in stock - Investing.com

Insider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 613 Shares of Stock - MarketBeat

Insider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 263 Shares of Stock - MarketBeat

Insider Sell: Elizabeth Cushman Sells Shares of Abbott Laborator - GuruFocus

Abbott (ABT) SVP Eric Shroff logs share sale and tax disposition - Stock Titan

Abbott Laboratories (ABT) EVP logs 4,997-share tax-withholding disposition on Form 4 - Stock Titan

Abbott (NYSE: ABT) EVP logs share sale and tax disposition - Stock Titan

Abbott (ABT) CEO Robert Ford disposes 30,308 shares for tax withholding - Stock Titan

Abbott (NYSE: ABT) EVP Morrone logs stock sale and tax share disposition - Stock Titan

Abbott Laboratories (ABT) EVP logs tax-withholding disposition of 8,577 shares - Stock Titan

[Form 4] ABBOTT LABORATORIES Insider Trading Activity - Stock Titan

Abbott Laboratories (NYSE: ABT) VP reports sale and tax share disposal - Stock Titan

Abbott Laboratories (ABT) CFO uses 7,441 shares to cover tax withholding - Stock Titan

Abbott (ABT) EVP logs stock sale and tax-withholding share disposal - Stock Titan

How FDA Approval of CardioMEMS Hero Remote Monitor At Abbott (ABT) Has Changed Its Investment Story - Yahoo Finance

Texas primary: Republicans try to knock Gov. Abbott off November ballot; Hinojosa and others vie for Democratic spot - KVUE

Abbott Labs Finishes Off Suit Over Google, Meta Data Sharing - Bloomberg Law News

Abbott Laboratories Spent $20 Billion to Enter Cancer Diagnostics: Why Analysts See 60% Upside - TIKR.com

Judge tosses class action suit accusing Abbott of sharing CGM data with Meta, Google - MassDevice

Exact Sciences Holders Back Abbott Deal As Valuation Gap Draws Focus - simplywall.st

Judge axes suit saying Abbott shared CGM data with Meta, Google - Drug Delivery Business

Personalized Nutrition Market Size to Reach USD 60.92 Billion by 2035; Expansion is Driven by the Surging Consumer Awareness Related to Preventive Healthcare Globally

Better Value & Growth: STE, RMD Lead Abbott Laboratories Stock - Trefis

Abbott Laboratories Stock: Is This Quiet Health Tech Giant Your Next Big US Play? - AD HOC NEWS

Is Abbott Laboratories (ABT) Pricing Look Attractive After Recent Share Price Weakness? - simplywall.st

Abbott Beats Data Sharing Suit Over Glucose Tracking Trial - Law360

[144] ABBOTT LABORATORIES SEC Filing - Stock Titan

Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance

Abbott Laboratories (ABT) Stock Analysis: A 14.64% Potential Upside Amidst Strong Buy Ratings - DirectorsTalk Interviews

Greg Abbott, Trump highlight energy and economy - El Paso Times

Abbott warns Iranian ‘sleeper cells’ must be taken ‘seriously’ after deadly Texas shooting

2 Reasons to Like ABT and 1 to Stay Skeptical - Yahoo Finance

Abbott wins FDA approval for updated heart failure monitoring device - MedTech Dive

Texas Gov. Abbott warns of sleeper cells after Austin shooting leaves 2 dead, 14 injured

Abbott Laboratories (NYSE:ABT) Emerges as a Top Dividend Stock with Strong Fundamentals - ChartMill

Fisher Asset Management LLC Raises Stock Position in Abbott Laboratories $ABT - MarketBeat

Abbott Laboratories $ABT Shares Sold by Laurel Wealth Advisors LLC - MarketBeat

Abbott Laboratories stock forecast for 2030: Exact Sciences acquisition reshapes growth outlook toward $180 - Traders Union

Antibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence

ABT.SW stock intraday: CHF88.00 falls 12.00% on SIX, analysts watch support - Meyka

Trump Vows 'American Energy Dominance' In Texas Rally Ahead Of Primary Elections

Rafferty Asset Management LLC Purchases 9,290 Shares of Abbott Laboratories $ABT - MarketBeat

APG Asset Management N.V. Acquires 12,600 Shares of Abbott Laboratories $ABT - MarketBeat